Last reviewed · How we verify
Calcium supplement with vitamin D
At a glance
| Generic name | Calcium supplement with vitamin D |
|---|---|
| Sponsor | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Influence of β-hydroxy β-methyl Butyrate (HMB)Supplementation on Post-operative Muscle Mass and Function in Female Athletes (PHASE2)
- This Study Investigates β-hydroxy-β-methylbutyrate (HMB) and 2-hydroxybenzylamine (2-HOBA), When Administered Either Individually or in Combination Contributes to an Increased Quality of Health, Specifically Improving Muscular Strength and Cognitive Functioning in Adults Over the Age of 65. (NA)
- Prunes Preventing Bone Loss in Perimenopause (NA)
- Pediatric Safety Follow-up Study of Prior Treatment With Romosozumab for Osteogenesis Imperfecta (PHASE3)
- Therapeutic Diets in Alzheimer's Disease (NA)
- Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1 (PHASE3)
- Micronutrient Dose Response Study in Bangladesh (NA)
- A Registry for Participants With Chronic Hypoparathyroidism
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: